PT2139986T - Utilização de temperatura baixa e/ou ph baixo em cultura de células - Google Patents

Utilização de temperatura baixa e/ou ph baixo em cultura de células

Info

Publication number
PT2139986T
PT2139986T PT87465266T PT08746526T PT2139986T PT 2139986 T PT2139986 T PT 2139986T PT 87465266 T PT87465266 T PT 87465266T PT 08746526 T PT08746526 T PT 08746526T PT 2139986 T PT2139986 T PT 2139986T
Authority
PT
Portugal
Prior art keywords
low
cell culture
low temperature
temperature
culture
Prior art date
Application number
PT87465266T
Other languages
English (en)
Inventor
Manuel Gomes Jose
Walter Hiller Gregory
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39493848&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2139986(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of PT2139986T publication Critical patent/PT2139986T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT87465266T 2007-04-23 2008-04-22 Utilização de temperatura baixa e/ou ph baixo em cultura de células PT2139986T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91338207P 2007-04-23 2007-04-23

Publications (1)

Publication Number Publication Date
PT2139986T true PT2139986T (pt) 2017-11-14

Family

ID=39493848

Family Applications (2)

Application Number Title Priority Date Filing Date
PT87465266T PT2139986T (pt) 2007-04-23 2008-04-22 Utilização de temperatura baixa e/ou ph baixo em cultura de células
PT87465282T PT2139987E (pt) 2007-04-23 2008-04-22 Métodos para a produção de proteína usando compostos antisenescência

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT87465282T PT2139987E (pt) 2007-04-23 2008-04-22 Métodos para a produção de proteína usando compostos antisenescência

Country Status (26)

Country Link
US (2) US20080274507A1 (pt)
EP (2) EP2139986B1 (pt)
JP (3) JP5557736B2 (pt)
KR (3) KR101560421B1 (pt)
CN (3) CN101679943A (pt)
AR (2) AR066238A1 (pt)
AU (2) AU2008242632B2 (pt)
BR (2) BRPI0810511A2 (pt)
CA (2) CA2684727C (pt)
CL (2) CL2008001156A1 (pt)
CO (2) CO6241165A2 (pt)
DK (2) DK2139986T3 (pt)
ES (2) ES2424217T3 (pt)
HK (2) HK1142095A1 (pt)
HU (1) HUE034776T2 (pt)
IL (2) IL201720A (pt)
MX (2) MX2009011363A (pt)
PA (2) PA8777701A1 (pt)
PE (2) PE20090731A1 (pt)
PL (2) PL2139986T3 (pt)
PT (2) PT2139986T (pt)
RU (2) RU2009138226A (pt)
SI (2) SI2139987T1 (pt)
TW (2) TW200902708A (pt)
WO (2) WO2008131374A1 (pt)
ZA (1) ZA200907426B (pt)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2527425A1 (en) 2006-09-13 2012-11-28 Abbott Laboratories Cell culture improvements
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
ES2541454T3 (es) 2007-03-02 2015-07-20 Wyeth Llc Uso de cobre y glutamato en cultivos celulares para producción de polipéptidos
ES2657055T3 (es) * 2007-08-09 2018-03-01 Wyeth Llc Uso de perfusión para mejorar la producción de un cultivo de células alimentado por lotes en biorreactores
WO2010034015A2 (en) 2008-09-22 2010-03-25 The Regents Of The University Of Colorado, A Body Corporate Modulating the alternative complement pathway
AU2009307737B2 (en) 2008-10-20 2015-07-23 Abbvie Inc. Viral inactivation during purification of antibodies
SG10201702922VA (en) * 2008-10-20 2017-06-29 Abbvie Inc Isolation and purification of antibodies using protein a affinity chromatography
RU2012127383A (ru) * 2009-12-02 2014-01-10 Акселерон Фарма Инк. Композиции и способы для увеличения времени полужизни fc-слитых белков в сыворотке
EP3330370B1 (en) 2010-04-26 2021-02-24 Novartis AG Process for cultivation of cho cells
SG191371A1 (en) 2010-12-28 2013-08-30 Chugai Pharmaceutical Co Ltd Animal cell culturing method
US9062106B2 (en) 2011-04-27 2015-06-23 Abbvie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
WO2012170938A1 (en) 2011-06-08 2012-12-13 Acceleron Pharma Inc. Compositions and methods for increasing serum half-life
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
KR20150043523A (ko) 2012-09-02 2015-04-22 애브비 인코포레이티드 단백질 불균일성의 제어 방법
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
CA2905010A1 (en) 2013-03-12 2014-09-18 Abbvie Inc. Human antibodies that bind human tnf-alpha and methods of preparing the same
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
US9499614B2 (en) 2013-03-14 2016-11-22 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
PL2970875T3 (pl) 2013-03-15 2020-08-10 F.Hoffmann-La Roche Ag Kompozycje do hodowli komórkowych z przeciwutleniaczami i sposoby wytwarzania polipeptydów
WO2014160790A1 (en) 2013-03-26 2014-10-02 Coherus Biosciences, Inc. Protein production method
WO2014182658A1 (en) * 2013-05-06 2014-11-13 Abbvie Inc. Compositions for cell culture and methods of using the same
EP3052640A2 (en) 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
USD759075S1 (en) * 2014-04-11 2016-06-14 Nutonian, Inc. Display screen with graphical user interface
USD759076S1 (en) * 2014-04-18 2016-06-14 Nutonian, Inc. Display screen with graphical user interface
TW202204596A (zh) 2014-06-06 2022-02-01 美商健臻公司 灌注培養方法及其用途
WO2016061065A1 (en) 2014-10-15 2016-04-21 Alexion Pharmaceuticals, Inc. Methods of shifting an isoelectric profile of a protein product and uses thereof
AR104050A1 (es) * 2015-03-26 2017-06-21 Chugai Pharmaceutical Co Ltd Proceso de producción con iones de cobre controlados
TWI797060B (zh) 2015-08-04 2023-04-01 美商再生元醫藥公司 補充牛磺酸之細胞培養基及用法
WO2017065559A1 (ko) * 2015-10-15 2017-04-20 (주)알테오젠 Igg fc 도메인을 가지는 융합 단백질의 생산방법
KR101936049B1 (ko) * 2015-10-15 2019-01-08 (주)알테오젠 IgG Fc 도메인을 가지는 융합 단백질의 생산방법
CN107460221B (zh) * 2016-06-02 2021-01-15 正大天晴药业集团股份有限公司 一种降低抗pd-l1抗体中蛋白聚合物的细胞培养方法
EP3529350A1 (en) 2016-10-19 2019-08-28 H. Hoffnabb-La Roche Ag Method for producing an immunoconjugate
KR20190117624A (ko) * 2017-02-17 2019-10-16 론자 리미티드 생물학적 생성물 변이체의 생산 방법
JP2020536497A (ja) * 2017-10-16 2020-12-17 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 細胞培養におけるプロセス変量を制御するためのインサイチュラマン分光システム及び方法
CA3118398A1 (en) * 2018-11-02 2020-05-07 WuXi Biologics Ireland Limited Cell culture process by intensified perfusion with continuous harvest and without cell bleeding
WO2020180967A1 (en) * 2019-03-04 2020-09-10 Amgen Inc. In vivo reversibility of high molecular weight species
CN115884793A (zh) 2020-01-09 2023-03-31 梅尔莎纳医疗公司 具有含肽接头的位点特异性抗体-药物缀合物
WO2022254319A1 (en) * 2021-06-01 2022-12-08 Pfizer Inc. Cell culture method for producing sfgfr3 polypeptide
KR102682066B1 (ko) * 2021-10-12 2024-07-05 프레스티지바이오로직스 주식회사 항체 집단의 제조 방법
CN118006716A (zh) * 2024-03-15 2024-05-10 通化安睿特生物制药股份有限公司 制备高表达且低o-糖基化水平的重组人白蛋白的方法

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5225539A (en) * 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5530101A (en) * 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5225538A (en) * 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
JPH0396383A (ja) 1989-09-08 1991-04-22 Riso Kagaku Corp 画像形成装置
DE59010933D1 (de) * 1989-09-12 2003-05-08 Hoffmann La Roche TFN-bindende Proteine
GB8927546D0 (en) 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US5859205A (en) * 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
US5610033A (en) 1990-04-25 1997-03-11 Novo Nordisk A/S Method of producing proteins with FVIII activity and/or FVIII derivatives
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
EP0571390B1 (en) * 1990-11-23 2000-03-08 Peptech Limited The delay, prevention and/or reversal of cell senescence
LU91067I2 (fr) * 1991-06-14 2004-04-02 Genentech Inc Trastuzumab et ses variantes et dérivés immuno chimiques y compris les immotoxines
US6136310A (en) * 1991-07-25 2000-10-24 Idec Pharmaceuticals Corporation Recombinant anti-CD4 antibodies for human therapy
EP0656946B2 (en) 1992-08-21 2010-03-31 Vrije Universiteit Brussel Immunoglobulins devoid of light chains
US5399677A (en) * 1993-12-07 1995-03-21 Genetics Institute, Inc. Mutants of bone morphogenetic proteins
US5516964A (en) * 1994-01-21 1996-05-14 Sun Company, Inc. (R&M) Hydrocarbon isomerization using solid superacid catalysts comprising platinum metal
US5705364A (en) 1995-06-06 1998-01-06 Genentech, Inc. Mammalian cell culture process
US5830761A (en) * 1995-06-07 1998-11-03 Genetics Institute, Inc. Medium and methods for culturing mammalian cho cells
WO1997008320A1 (en) * 1995-08-18 1997-03-06 Morphosys Gesellschaft Für Proteinoptimierung Mbh Protein/(poly)peptide libraries
JP4306813B2 (ja) 1995-09-19 2009-08-05 アスビオファーマ株式会社 動物細胞の新規培養方法
US5710023A (en) * 1996-03-01 1998-01-20 Genetics Institute, Inc. IL-13 cytokine receptor chain
US6146847A (en) * 1996-11-01 2000-11-14 Genespan Corporation Stabilized transient gene expression
CA2722378C (en) * 1996-12-03 2015-02-03 Amgen Fremont Inc. Human antibodies that bind tnf.alpha.
TR200504220T2 (tr) * 1998-12-17 2007-04-24 Biogen Idec Ma Inc. Aktif limfotoksin-beta reseptör imunoglobülin şimeAktif limfotoksin-beta reseptör imunoglobülin şimerik proteinlerinin yüksek düzey ifadesi ve saflaştrik proteinlerinin yüksek düzey ifadesi ve saflaştırılması için bir yöntem.ırılması için bir yöntem.
US7294481B1 (en) 1999-01-05 2007-11-13 Immunex Corporation Method for producing recombinant proteins
JP3090657B1 (ja) 1999-08-09 2000-09-25 伸子 蓮山 ゼオライト製造方法およびゼオライト製造装置
AUPR038200A0 (en) * 2000-09-26 2000-10-19 Beta Peptide Foundation Pty Ltd, The Compositions and methods for delaying, preventing, rejuvenating or reversing senescence
US20030133939A1 (en) * 2001-01-17 2003-07-17 Genecraft, Inc. Binding domain-immunoglobulin fusion proteins
US7829084B2 (en) * 2001-01-17 2010-11-09 Trubion Pharmaceuticals, Inc. Binding constructs and methods for use thereof
US7754208B2 (en) * 2001-01-17 2010-07-13 Trubion Pharmaceuticals, Inc. Binding domain-immunoglobulin fusion proteins
US20030040095A1 (en) * 2001-03-16 2003-02-27 Achille Arini Method for the production of pharmaceutically active recombinant proteins
US20040058445A1 (en) * 2001-04-26 2004-03-25 Ledbetter Jeffrey Alan Activation of tumor-reactive lymphocytes via antibodies or genes recognizing CD3 or 4-1BB
US6544076B2 (en) 2001-07-10 2003-04-08 Alan L. Pocrass Dual function RJ connector
CA2464616C (en) * 2001-11-19 2012-07-24 Are Bogsnes Process for preparing insulin compounds
CA2417689C (en) 2002-03-05 2006-05-09 F. Hoffmann-La Roche Ag Improved methods for growing mammalian cells in vitro
WO2003083066A2 (en) * 2002-03-27 2003-10-09 Immunex Corporation Methods for increasing polypeptide production
GB0208041D0 (en) 2002-04-08 2002-05-22 Lonza Biologics Plc Method of culturing animal cells
ES2394085T3 (es) 2002-07-09 2013-01-17 Baxter International Inc. Medio exento de proteínas animales para el cultivo de células
ES2285188T3 (es) 2002-07-15 2007-11-16 Immunex Corporation Metodo y medios para controlar sialilacion de proteinas producidas por celulas de mamifero.
US6924124B1 (en) 2002-08-23 2005-08-02 Immunex Corporation Feeding strategies for cell culture
US7541164B2 (en) 2002-12-23 2009-06-02 Bristol-Myers Squibb Company Mammalian cell culture processes for protein production
AU2004234377A1 (en) 2003-04-25 2004-11-11 Immunex Corporation Inducers of recombinant protein expression
CN1565631A (zh) * 2003-06-27 2005-01-19 上海中信国健药业有限公司 肿瘤坏死因子受体－免疫球蛋白的融合蛋白用于急性肺损伤药物的用途
ES2364388T3 (es) * 2004-07-07 2011-09-01 Coloplast A/S Preparación de revestimientos hidrófilos utilizando un compuesto de 1,3-dioxolano.
US7294484B2 (en) * 2004-08-27 2007-11-13 Wyeth Research Ireland Limited Production of polypeptides
US7300773B2 (en) * 2004-08-27 2007-11-27 Wyeth Research Ireland Limited Production of TNFR-Ig
US7335491B2 (en) * 2004-08-27 2008-02-26 Wyeth Research Ireland Limited Production of anti-abeta
US7426440B2 (en) * 2004-09-24 2008-09-16 Nutritional Bioscience Ltd. Repair and protection factor scoring method for bioactive agents
US20070102622A1 (en) 2005-07-01 2007-05-10 Olsen Richard I Apparatus for multiple camera devices and method of operating same
DE102005034616B4 (de) * 2005-07-18 2008-07-03 Elringklinger Ag Brennstoffzelleneinheit und Brennstoffzellenstapel
AR058140A1 (es) * 2005-10-24 2008-01-23 Wyeth Corp Metodo de produccion proteica utilizando compuestos anti-senescencia
PT2495307T (pt) * 2006-07-13 2018-05-10 Wyeth Llc Produção do fator ix de coagulação com padrão melhorado de glicosilação
ES2541454T3 (es) 2007-03-02 2015-07-20 Wyeth Llc Uso de cobre y glutamato en cultivos celulares para producción de polipéptidos
ES2657055T3 (es) 2007-08-09 2018-03-01 Wyeth Llc Uso de perfusión para mejorar la producción de un cultivo de células alimentado por lotes en biorreactores

Also Published As

Publication number Publication date
EP2139986A1 (en) 2010-01-06
DK2139987T3 (da) 2013-09-02
IL201720A (en) 2016-03-31
PL2139987T3 (pl) 2013-11-29
CO6241165A2 (es) 2011-01-20
CO6241166A2 (es) 2011-01-20
KR101560421B1 (ko) 2015-10-15
JP5881755B2 (ja) 2016-03-09
RU2009138226A (ru) 2011-05-27
CN101679943A (zh) 2010-03-24
CN101668845B (zh) 2015-11-25
AU2008242633A1 (en) 2008-10-30
ES2646090T3 (es) 2017-12-12
CA2685552C (en) 2016-02-23
KR20140132016A (ko) 2014-11-14
AU2008242632A1 (en) 2008-10-30
EP2139987B9 (en) 2013-11-13
PE20090153A1 (es) 2009-04-23
AR066239A1 (es) 2009-08-05
JP5557736B2 (ja) 2014-07-23
HK1216261A1 (zh) 2016-10-28
JP2010524503A (ja) 2010-07-22
KR20100016271A (ko) 2010-02-12
EP2139986B1 (en) 2017-09-06
WO2008131375A1 (en) 2008-10-30
PE20090731A1 (es) 2009-07-15
PT2139987E (pt) 2013-08-22
TW200902709A (en) 2009-01-16
US20080274507A1 (en) 2008-11-06
JP2010524504A (ja) 2010-07-22
CN101668845A (zh) 2010-03-10
RU2009139054A (ru) 2011-05-27
US9988662B2 (en) 2018-06-05
BRPI0810482A2 (pt) 2014-10-07
PA8777701A1 (es) 2008-11-19
ES2424217T3 (es) 2013-09-30
JP2014113161A (ja) 2014-06-26
IL201719A0 (en) 2011-08-01
PL2139986T3 (pl) 2018-01-31
BRPI0810511A2 (pt) 2014-10-07
HK1142095A1 (zh) 2010-11-26
CA2684727A1 (en) 2008-10-30
PA8778001A1 (es) 2008-11-19
AR066238A1 (es) 2009-08-05
MX2009011362A (es) 2009-11-05
KR20100017211A (ko) 2010-02-16
IL201719A (en) 2015-09-24
AU2008242632B2 (en) 2013-11-28
EP2139987B1 (en) 2013-07-03
ES2424217T9 (es) 2014-01-27
TW200902708A (en) 2009-01-16
DK2139987T5 (da) 2014-01-27
EP2139987A1 (en) 2010-01-06
ZA200907426B (en) 2010-08-25
SI2139987T1 (sl) 2013-09-30
WO2008131374A1 (en) 2008-10-30
RU2478702C2 (ru) 2013-04-10
AU2008242633B2 (en) 2014-09-18
DK2139986T3 (en) 2017-10-02
IL201720A0 (en) 2011-08-01
KR101540124B1 (ko) 2015-07-28
CN105039473A (zh) 2015-11-11
CA2684727C (en) 2018-09-04
CL2008001159A1 (es) 2008-11-03
US20080269132A1 (en) 2008-10-30
HUE034776T2 (en) 2018-02-28
CL2008001156A1 (es) 2009-01-16
SI2139986T1 (sl) 2017-11-30
MX2009011363A (es) 2009-11-05
CA2685552A1 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
HK1216261A1 (zh) 低溫和/或低 值在細胞培養中的使用
IL197684A0 (en) Stem cell culture medium and methods of use thereof
ZA200810412B (en) Placental niche and use thereof to culture stem cells
EP1988159A4 (en) CULTURE MEDIUM ADDITIVE FOR ANIMAL CELL FREE SERUM, KIT AND USE OF THE ADDITIVE OR KIT
PL3323883T3 (pl) Zdefiniowane powierzchnie do hodowli komórkowej i sposoby użycia
HK1138374A1 (en) Methods of evaluating cells and cell cultures
EP2185681A4 (en) CONCENTRATION AND ENRICHMENT OF MICROBIAL CELLS AND MICROBIAL NUCLEIC ACIDS FROM BODY FLUIDS
PT2115126E (pt) Utilização de cobre e glutamato na cultura de células para a produção de polipeptídeos
IL221384A0 (en) Improving il-15 and il-15r-alpha for expression in mammalian cells
PL2257155T3 (pl) Krioprezerwacja komórek i tkanek biologicznych
EP2189519A4 (en) CELL CULTURE INSTRUMENT AND CELL CUKLTURE PROCESS WITH THIS
EP2181482A4 (en) DESIGNING A BATTERY ELEMENT AND METHODS FOR ITS CONSTRUCTION
HK1207883A1 (en) Cell culture method and utilization of the same
ZA200901914B (en) Stem cell culture medium and method
GB2460552B (en) Stem cell culture media and methods
GB2442084B (en) Flow-through cell and method of use
GB2450337B (en) Cell culture and mixing vessel
GB0608054D0 (en) Production and use of regulatory t cells
ZA201101137B (en) Prf in cell and tissue culture
EP2115127A4 (en) METHOD AND COMPOSITIONS FOR IMPROVING CELL HEALTH IN CULTURES
EP2334693A4 (en) METHODS OF LONG-TERM CULTURE OF EUKARYOTIC CELLS AND USES THEREOF
AU2007906441A0 (en) Cell culture vessel and method of use
AU2007905987A0 (en) Cell culture media and methods of use thereof
AU2007905979A0 (en) Cell culture media and methods of use thereof
AU2007905966A0 (en) Cell culture media and methods of use thereof